684 related articles for article (PubMed ID: 16273029)
1. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
[TBL] [Abstract][Full Text] [Related]
2. Mutant-prevention concentrations of enrofloxacin for Escherichia coli isolates from chickens.
Li Q; Bi X; Diao Y; Deng X
Am J Vet Res; 2007 Aug; 68(8):812-5. PubMed ID: 17669019
[TBL] [Abstract][Full Text] [Related]
3. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.
Lautenbach E; Fishman NO; Metlay JP; Mao X; Bilker WB; Tolomeo P; Nachamkin I
J Infect Dis; 2006 Jul; 194(1):79-85. PubMed ID: 16741885
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
Lee JK; Lee YS; Park YK; Kim BS
Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
[TBL] [Abstract][Full Text] [Related]
6. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
7. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.
Sáenz Y; Zarazaga M; Briñas L; Ruiz-Larrea F; Torres C
J Antimicrob Chemother; 2003 Apr; 51(4):1001-5. PubMed ID: 12654733
[TBL] [Abstract][Full Text] [Related]
8. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
Guo Y; Pei X; Liu X
Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
[TBL] [Abstract][Full Text] [Related]
9. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
Lei YC; Wang HB; Sun ZY; Shen ZY
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of point mutations in the ygeD, gyrA and parC genes in fluoroquinolones resistant clinical isolates of Chlamydia trachomatis].
Misiurina OIu; Shipitsina EV; Finashutina IuP; Lazarev VN; Akopian TA; Savicheva AM; Govorun VM
Mol Gen Mikrobiol Virusol; 2004; (3):3-7. PubMed ID: 15354934
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of Escherichia coli gyrA and parC mutants in one-day-old broiler chicks in Iran.
Abdi-Hachesoo B; Asasi K; Sharifiyazdi H
Vet Ital; 2013; 49(3):291-7. PubMed ID: 24358491
[TBL] [Abstract][Full Text] [Related]
13. Rapid detection of gyrA and parC mutations in quinolone-resistant Salmonella enterica using Pyrosequencing technology.
Hopkins KL; Arnold C; Threlfall EJ
J Microbiol Methods; 2007 Jan; 68(1):163-71. PubMed ID: 16934351
[TBL] [Abstract][Full Text] [Related]
14. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
[TBL] [Abstract][Full Text] [Related]
15. Rapid detection of gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae by denaturing high-performance liquid chromatography.
Shigemura K; Shirakawa T; Okada H; Tanaka K; Udaka T; Kamidono S; Arakawa S; Gotoh A
J Microbiol Methods; 2004 Dec; 59(3):415-21. PubMed ID: 15488283
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
17. Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia.
Uchida Y; Mochimaru T; Morokuma Y; Kiyosuke M; Fujise M; Eto F; Harada Y; Kadowaki M; Shimono N; Kang D
Int J Antimicrob Agents; 2010 Apr; 35(4):387-91. PubMed ID: 20138480
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
Chenia HY; Pillay B; Pillay D
J Antimicrob Chemother; 2006 Dec; 58(6):1274-8. PubMed ID: 17040923
[TBL] [Abstract][Full Text] [Related]
19. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
Yang J; Luo Y; Cui S; Wang W; Han L
Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
[TBL] [Abstract][Full Text] [Related]
20. Analysis of gyrA and parC mutations in enterococci from environmental samples with reduced susceptibility to ciprofloxacin.
Petersen A; Jensen LB
FEMS Microbiol Lett; 2004 Feb; 231(1):73-6. PubMed ID: 14769469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]